Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair

W Cai, T Yang, H Liu, L Han, K Zhang, X Hu… - Progress in …, 2018 - Elsevier
Peroxisome proliferator-activated receptor γ (PPARγ) is a widely expressed ligand-
modulated transcription factor that governs the expression of genes involved in …

Involvement of PPAR nuclear receptors in tissue injury and wound repair

L Michalik, W Wahli - The Journal of clinical investigation, 2006 - Am Soc Clin Investig
Tissue damage resulting from chemical, mechanical, and biological injury, or from
interrupted blood flow and reperfusion, is often life threatening. The subsequent tissue …

Porcine models for studying complications and organ crosstalk in diabetes mellitus

S Renner, A Blutke, S Clauss, CA Deeg, E Kemter… - Cell and tissue …, 2020 - Springer
The worldwide prevalence of diabetes mellitus and obesity is rapidly increasing not only in
adults but also in children and adolescents. Diabetes is associated with macrovascular …

Cardiac peroxisome proliferator-activated receptor δ is essential in protecting cardiomyocytes from oxidative damage

G Ding, M Fu, Q Qin, W Lewis, HW Kim… - Cardiovascular …, 2007 - academic.oup.com
Objectives Peroxisome proliferator-activated receptors (PPAR) α and β/δ are essential
transcriptional regulators of fatty acid oxidation in the heart. However, little is known about …

Significance of peroxisome proliferator-activated receptors in the cardiovascular system in health and disease

E Robinson, DJ Grieve - Pharmacology & therapeutics, 2009 - Elsevier
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated nuclear
transcription factors that belong to the nuclear receptor superfamily. Three isoforms of PPAR …

Peroxisome proliferator-activated receptor gamma as a drug target in the pathogenesis of insulin resistance

L Guo, R Tabrizchi - Pharmacology & therapeutics, 2006 - Elsevier
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription
factors that belong to the nuclear hormone receptor superfamily. The activation of PPAR …

Biology and therapeutic applications of peroxisome proliferator-activated receptors

MP Menendez-Gutierrez, T Roszer… - Current topics in …, 2012 - ingentaconnect.com
Peroxisome proliferator-activated receptors (PPARs) are ligand dependent transcription
factors. The three mammalian PPARs are key regulators of fatty acid and lipoprotein …

PPARγ in ischemia-reperfusion injury: overview of the biology and therapy

R Huang, C Zhang, X Wang, H Hu - Frontiers in Pharmacology, 2021 - frontiersin.org
Ischemia-reperfusion injury (IRI) is a complex pathophysiological process that is often
characterized as a blood circulation disorder caused due to various factors (such as …

Dramatic synergistic anticancer effect of clinically achievable doses of lovastatin and troglitazone

CJ Yao, GM Lai, CF Chan, AL Cheng… - … Journal of Cancer, 2006 - Wiley Online Library
Lovastatin (an HMG‐CoA reductase inhibitor) and troglitazone (a PPAR‐γ agonist) have
been intensively studied prospectively for their application in cancer treatment. However …

The cyclopentenone prostaglandin 15-deoxy-Δ12,14-prostaglandin J2 ameliorates ischemic acute renal failure

PK Chatterjee, NSA Patel, S Cuzzocrea… - Cardiovascular …, 2004 - academic.oup.com
Objective: Here we investigate the effects of the endogenous prostaglandin D2 metabolite
15-deoxy-Δ12, 14-prostaglandin J2, on the renal dysfunction and injury caused by …